Toward a tailored therapeutic prescription for patients with axial spondyloarthritis-Reference-Cited by-同舟云学术

Toward a tailored therapeutic prescription for patients with axial spondyloarthritis

Published:2021-03 Issue:2 Volume:88 Page:105019
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Goupille Philippe,Wendling Daniel

Publisher

Elsevier BV

Subject

Rheumatology

Reference26 articles.

1. 2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis;Wendling;Joint Bone Spine,2018

2. Are the recommendations for the use of anti-TNF drugs during axial spondyloarthritis relevant for non-radiographic forms?;Goupille;Joint Bone Spine,2020

3. Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis;Wendling;Expert Opin Biol Ther,2019

4. Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism?;Wendling;Joint Bone Spine,2020

5. Secukinumab 150mg Significantly Improved Signs and Symptoms of Non-radiographic Axial Spondyloarthritis: Results from a Phase 3 Double-blind. Randomized, Placebo-controlled Study;Deodhar;Arthritis Rheumatol,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initial C-reactive protein level: Discriminating between anti-TNF and anti-IL-17 agents as the first biologic treatment for axial spondyloarthritis?;Joint Bone Spine;2024-05

2. Le concept de maladie difficile à traiter (D2T) est-il applicable à la spondyloarthrite axiale ?;Revue du Rhumatisme;2023-12

3. Le niveau initial de protéine C réactive : un élément de choix discriminant entre anti-TNF et anti-IL17 en premier traitement biologique ciblé de la spondyloarthrite axiale ?;Revue du Rhumatisme;2023-12

4. Is the Difficult-to-Treat (D2T) concept applicable to axial spondyloarthritis?;Joint Bone Spine;2023-05

5. Rhumatisme psoriasique axial : nouvelle entité ou simple forme clinique ?;Revue du Rhumatisme;2022-12